Alteplase is a thrombolytic medication used for the treatment of acute myocardial infarctions and other severe conditions that are caused due to blood clotting. This thrombolytic medication works by breaking up and dissolving the blood clots that can result in artery blockage. It is manufactured by recombinant DNA technology and given by injection into a vein or artery. It is sterile and purified glycoprotein of 527 amino acids. It is also known as Activate and synthesized using the complementary DNA (cDNA) for natural human tissue type plasminogen activator which is obtained from the human melanoma cell line. Data Bridge Market Research analyses that the alteplase market which was USD 1,284.87 million in 2023, would rocket up to USD 1,827.04 million by 2030, and is expected to undergo a CAGR of 5.1% during the forecast period. This indicates that the market value. "Incomplete spinal injury" dominates the type segment of the alteplase market due to increased road accidents.
When is alteplase given?
Activase (alteplase) is indicated for the treatment of acute ischemic stroke. Exclude intracranial hemorrhage as the primary cause of stroke signs and symptoms prior to initiation of treatment. Initiate treatment as soon as possible but within 3 hours after symptom onset.
What is the drug alteplase used for?
ALTEPLASE (AL te plase) can dissolve blood clots that form in the heart, blood vessels, or lungs after a heart attack. This medicine is also given to improve recovery and decrease the chance of disability in patients having symptoms of a stroke.
Get the sample copy of Report @- https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-alteplase-market
The alteplase market is segmented on the basis of product type, dosage, application, end user and distribution channel. The growth amongst these segments will help you ze meagre growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.
Product Type
- Powder
- Solution
- Others
Dosage
- 2 mg
- 50 mg
- 100 mg
Application
- Acute Ischemic Stroke
- Acute Myocardial Infarction
- Acute Massive Pulmonary Embolism
- Others
End User
- Clinic
- Hospital
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Highlight of Table of Content:
- Chapter 1: Market overview
- Chapter 2: Global Ateplase Market analysis
- Chapter 3: Regional analysis of the Global Ateplase Market
- Chapter 4: Market segmentation based on types and applications
- Chapter 5: Revenue analysis based on types and applications
- Chapter 6: Market share
- Chapter 7: Competitive Landscape
- Chapter 8: Drivers, Restraints, Challenges, and Opportunities
- Chapter 9: Gross Margin and Price Analysis
Some of the major players operating in the alteplase market are:
- Boehringer Ingelheim International GmbH (Germany)
- Kyowa Kirin Co., Ltd. (Japan)
- Genentech, Inc. (U.S.)
- Mitsubishi Tanabe Pharma Corporation (Japan)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Microbix Biosystems (Canada)
- medac GmbH (Germnay)
- MOCHIDA PHARMACEUTICAL CO., LTD. (Japan)
- Taj Pharma (India) Ltd., (India)
- Sedico Co. (Egypt)
Profound Questions Answered in this Report:
- What is the growth rate of various stages in the value chain of the industry?
- Which region has the highest growth rate and size of the emerging market by value in 2022?
- Who are the competitive players in Global Ateplase Market?
- Which region has the largest share and degree of competition in the industry?
- What is the CAGR of the market during the forecast period 2023 to 2030?
- Which region is expected to hold the highest market share for the market?
- What is the main driver of the Global Ateplase Market?
- What is sales volume, revenue, and price analysis of top players of the market?
- What are the market opportunities and threats faced by the vendors in the industry?
- What has been the impact of COVID-19 on the Global Ateplase Market?
Asceses Full report@ https://www.databridgemarketresearch.com/reports/global-alteplase-market
Browser Related Report@-
North America Pelvic Floor Electric Stimulator Market Size, Share, Trends, Growth and Demand
Pharmaceutical Isolator Market Size, Share, Trends, Growth and Demand
Asia-Pacific Pharmaceutical Isolator Market Size, Share, Trends, Growth and Demand
Europe Pharmaceutical Isolator Market Size, Share, Trends, Growth and Demand
Middle East and Africa Pharmaceutical Isolator Market Size, Share, Trends, Growth and Demand
North America Pharmaceutical Isolator Market Size, Share, Trends, Growth and Demand
Asia-Pacific Psychedelic Drugs Market Size, Share, Trends, Growth and Demand
Europe Psychedelic Drugs Market Size, Share, Trends, Growth and Demand
Middle East and Africa Psychedelic Drugs Market Size, Share, Trends, Growth and Demand
North America Psychedelic Drugs Market Size, Share, Trends, Growth and Demand
Europe Rehabilitation Therapy Services Market Size, Share, Trends, Growth and Demand
U.S. Telestroke Market Size, Share, Trends, Growth and Demand
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
